Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma

被引:6
|
作者
Feng, Linxiang [1 ,2 ]
Feng, Zian [1 ,2 ]
Hu, Jie [1 ,2 ]
Gao, Jiahui [1 ,2 ]
Li, Ang [1 ,2 ]
He, Xiaodong [1 ,2 ]
Liu, Liu [1 ,2 ]
Shen, Zuojun [1 ,2 ]
机构
[1] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Lab Med, Div Life Sci & Med, Hefei, Anhui, Peoples R China
[2] Natl Clin Res Ctr Lab Med, Core Unit, Hefei, Peoples R China
基金
中国国家自然科学基金;
关键词
lung adenocarcinoma; exosome; miRNA; bioinformatics; qRT-PCR; CANCER; PROGRESSION; MIR-619-5P; ANGIOGENESIS; METASTASIS; PROMOTES; BIOLOGY;
D O I
10.3389/fgene.2023.1138230
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Introduction: Lung cancer has long been at the forefront of all cancers in terms of incidence and mortality. Lung adenocarcinoma is the most common type of lung cancer, accounting for 40% of all lung cancer types. Exosomes can act as biomarkers of tumors and thus play an important role.Methods: In this article, high-throughput sequencing of miRNAs in plasma exosomes from lung adenocarcinoma patients and healthy individuals was performed to obtain 87 upregulated miRNAs, which were then combined with data from the GSE137140 database uploaded by others for screening. The database included 1566 preoperative lung cancer patients, 180 postoperative patients, and 1774 non-cancerous controls. We overlapped the miRNAs upregulated in the serum of lung cancer patients in the database relative to those of non-cancer controls and post-operative patients with the upregulated miRNAs obtained from our next-generation sequencing to obtain nine miRNAs. Two miRNAs that were not reported as tumor markers in lung cancer, hsa-miR-4454 and hsa-miR-619-5p, were selected from them and then validated by qRT-PCR, and further analysis of miRNAs was performed using bioinformatics.Results: Real-time quantitative PCR showed that the expression levels of hsa-miR-4454 and hsa-miR-619-5p in plasma exosomes of patients with lung adenocarcinoma were significantly up-regulated. The AUC values of hsa-miR-619-5p and hsa-miR-4454 were 0.906 and 0.975, respectively, both greater than 0.5, showing good performance. The target genes of miRNAs were screened by bioinformatics methods, and the regulatory network between miRNAs and lncRNAs and mRNAs was studied.Discussion: Our work demonstrated that hsa-miR-4454 and hsa-miR-619-5p have the potential to be used as biomarkers for the early diagnosis of lung adenocarcinoma.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Plasma Level of hsa-miR-619-5p microRNA Is Associated with Prostatic Cancer Dissemination beyond the Capsule
    Shkurnikov, M. Yu.
    Makarova, Yu. A.
    Knyazev, E. N.
    Fomicheva, K. A.
    Galatenko, A. V.
    Nyushko, K. M.
    Galatenko, V. V.
    Vechorko, V. I.
    Alekseev, B. Ya.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2017, 163 (04) : 475 - 477
  • [2] Identification of exosomal hsa-miR-483-5p as a potential biomarker for hepatocellular carcinoma via microRNA expression profiling of tumor-derived exosomes
    Lin, Jie
    Lin, Wansong
    Bai, Yannan
    Liao, Yanling
    Lin, Qiaoyan
    Chen, Lingfeng
    Wu, Yijuan
    EXPERIMENTAL CELL RESEARCH, 2022, 417 (02)
  • [3] Exosomal hsa-miR-151a-3p and hsa-miR-877-5p are potential novel biomarkers for predicting bone metastasis in lung cancer
    Zhao, Kun
    Jia, Changji
    Wang, Jin
    Shi, Weiye
    Wang, Xiaoying
    Song, Yan
    Peng, Changliang
    AGING-US, 2023, 15 (24): : 14864 - 14888
  • [4] MicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer
    Li, Lei
    Feng, Tienan
    Zhang, Weituo
    Gao, Sumeng
    Wang, Ruoyang
    Lv, Wenwen
    Zhu, Tengteng
    Yu, Herbert
    Qian, Biyun
    INTERNATIONAL JOURNAL OF GENOMICS, 2020, 2020
  • [5] Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis
    Liu, Min
    Mo, Fei
    Song, Xiaohan
    He, Yun
    Yuan, Yan
    Yan, Jiaoyan
    Yang, Ye
    Huang, Jian
    Zhang, Shu
    PEERJ, 2021, 9
  • [6] Peiminine Enhances Doxorubicin Cytotoxicity and Downregulates hsa-miR-106a-5p and hsa -miR-181a-5p in Human Gastric Adenocarcinoma Cells
    Hedayati, Shirin
    Soltanzadeh, Hossein
    Ghaleh, Hadi Esmaeili Gouvarchin
    Bonab, Zahra Hojjati
    Alvanegh, Akbar Ghorbani
    ADVANCED BIOMEDICAL RESEARCH, 2024, 13 (01):
  • [7] Potential of hsa-miR200a-3p and hsa-miR502-3p as blood-based biomarker for Alzheimer's disease
    Biglari, Negin
    Khalaj-Kondori, Mohammad
    Ghasemi, Tayyebeh
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (12) : 11925 - 11932
  • [8] Potential of hsa-miR200a-3p and hsa-miR502-3p as blood-based biomarker for Alzheimer’s disease
    Negin Biglari
    Mohammad Khalaj-Kondori
    Tayyebeh Ghasemi
    Molecular Biology Reports, 2022, 49 : 11925 - 11932
  • [9] Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response
    Yacob, Aliza Mohd
    Muhamad, Nor Asiah
    Chang, Kian Meng
    Hisham, Hamidah Akmal
    Yusoff, Yuslina Mat
    Ibrahim, Latifah
    BMC CANCER, 2022, 22 (01)
  • [10] hsa_circ_0008234 inhibits the progression of lung adenocarcinoma by sponging miR-574-5p
    Jiang, Wei
    He, Yaozhou
    Ma, Zijian
    Zhang, Yu
    Zhang, Chengpeng
    Zheng, Nianpeng
    Tang, Xing
    CELL DEATH DISCOVERY, 2021, 7 (01)